Vascular Risk Clinical Trials

1 recruiting

Vascular Risk Trials at a Glance

50 actively recruiting trials for vascular risk are listed on ClinicalTrialsFinder across 6 cities in 43 countries. The largest study group is Not Applicable with 21 trials, with the heaviest enrollment activity in London, Cleveland, and Berlin. Lead sponsors running vascular risk studies include Charite University, Berlin, Germany, Consorzio Mario Negri Sud, and Oregon Health and Science University.

Browse vascular risk trials by phase

Treatments under study

About Vascular Risk Clinical Trials

Looking for clinical trials for Vascular Risk? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vascular Risk trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vascular Risk clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 50 trials

Recruiting
Phase 3

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled597 locationsNCT07181109
Recruiting
Phase 3

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting

A Hospital-Based Registry of Preventive Cardiology Clinics

Cardiovascular MorbidityCardiovascular Risk AssesmentPrimary Prevention CVD
National Institute of Cardiovascular Diseases, Pakistan10,000 enrolled1 locationNCT06503341
Recruiting
Not Applicable

Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)

Heart FailureCardiovascular Risk Factors
Idoven 1903 S.L.1,968 enrolled5 locationsNCT07113223
Recruiting
Not Applicable

Impact of the Corrie Lipids Digital Health Program on Lipid Optimization

LipidsDigital HealthCardiovascular Risk+2 more
Johns Hopkins University1,000 enrolled1 locationNCT07478887
Recruiting
Not Applicable

Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans

Cardiovascular Risk Factor
University of Delaware90 enrolled1 locationNCT04101188
Recruiting
Not Applicable

Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study

ObesityHypertensionOverweight+4 more
Universidad Católica San Antonio de Murcia220 enrolled1 locationNCT07447362
Recruiting

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Blood PressureNeuropathyDiabetes+6 more
Jaeb Center for Health Research200 enrolled18 locationsNCT06837181
Recruiting
Not Applicable

Sleep and Circadian Mechanisms in Hypertension

Cardiovascular DiseasesHypertensionSleep+2 more
Oregon Health and Science University32 enrolled1 locationNCT05184933
Recruiting
Not Applicable

Velocity-Based Resistance Training in Kidney Transplant Recipients

Metabolic SyndromeCardiovascular Risk FactorsKidney Transplant Recipients
Fundación Universitaria del Area Andina12 enrolled1 locationNCT07370727
Recruiting
Not Applicable

Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CVRISK-IT)

Cardiovascular RiskGenetic Cardiovascular Risk
IRCCS Policlinico S. Donato30,000 enrolled17 locationsNCT06832644
Recruiting
Not Applicable

Akershus Cardiac Examination (ACE) 5 Study

Lung Cancer ScreeningHeavy SmokersCardiovascular Risk Profile+1 more
University Hospital, Akershus1,000 enrolled1 locationNCT07301489
Recruiting
Phase 3

Effect of Metformin Use on Weight Loss in Obese, Non-diabetic People (MOWRI)

Insulin ResistanceObesity and Cardiovascular RiskObesity (Body Mass Index >30 kg/m2)
University Of Nigeria Teaching Hospital220 enrolled2 locationsNCT07297290
Recruiting

Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure

Heart Failure With Reduced Ejection FractionCardiovascular Risk FactorHeart Failure With Mid Range Ejection Fraction+2 more
Massachusetts General Hospital3,000 enrolled1 locationNCT03480633
Recruiting
Not Applicable

The Effect of a Digital Heart Health App and Lifestyle Intervention for Heart Disease in Primary Care.

Cardiovascular DiseasesCholesterolDyslipidemia+2 more
University of Toronto1,100 enrolled1 locationNCT06919302
Recruiting
Phase 2

Reducing Systemic Inflammation in People on Antiretroviral Therapy

Cardiovascular Risk FactorHuman Immunodeficiency Virus (HIV)
Centre hospitalier de l'Université de Montréal (CHUM)150 enrolled1 locationNCT07030920
Recruiting
Not Applicable

Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

Cardiovascular Risk FactorDietary Modification
The Cleveland Clinic170 enrolled1 locationNCT02016430
Recruiting

Diurnal BP Patterns in Those at Increased Risk of CVD

Arterial StiffnessChronic Kidney DiseasesBlood Pressure+1 more
University of Edinburgh120 enrolled1 locationNCT04522765
Recruiting

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

Heart FailureCardiovascular DiseasesStroke+21 more
Herlev and Gentofte Hospital1,000 enrolled1 locationNCT04950218
Recruiting

Aging of the Vascular Wall

Aging DisorderVascular Risk
Centre Hospitalier Universitaire de Saint Etienne30 enrolled1 locationNCT07122427